VestGen Advisors’s GSK GSK Stock Holding History

VestGen Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Sell	26,409 -156	-0.6%	-$8.25K	0.04%	380
2026 Q1	$1.35M	Buy	26,565 +1,286	+5%	+$69.7K	0.04%	387
2025 Q4	$1.24M	Sell	25,279 -61,951	-71%	-$2.89M	0.05%	316
2025 Q3	$3.76M	Buy	87,230 +2,555	+3%	+$99.8K	0.13%	161
2025 Q2	$3.19M	Sell	84,675 -4,170	-5%	-$159K	0.13%	162
2025 Q1	$3.44M	Buy	+88,845	New	+$3.25M	0.16%	136

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

VestGen Advisors's GSK Position: Q2 2026 in Review

VestGen Advisors reduced its GSK (GSK) stake by 0.59% in Q2 2026, selling an estimated $8.25K and leaving 26,409 shares worth $1.38M. The position accounts for 0.04% of the portfolio, ranked #380.

VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.76M in Q3 2025. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

VestGen Advisors held 26,409 shares of GSK worth $1.38M as of Q2 2026.
VestGen Advisors sold 156 GSK shares in Q2 2026, an estimated $8.25K.
GSK made up 0.04% of VestGen Advisors's portfolio in Q2 2026, its #380 holding.
VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
VestGen Advisors's GSK position peaked at $3.76M in Q3 2025.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.